D-0106-2027 Class II Ongoing
FDA drug recall D-0106-2027 was initiated by Eagle Pharma Outsourcing LLC on Oct 8, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 5 500-mL containers.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 4, 2026
- Initiation Date
- Oct 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5 500-mL containers
Product description
OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide within the U.S
Code information
Lot: OXY30-1006, Expiry: 10/10/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0106-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026